Xiling Shen
Overview:
Dr. Shen’s research interests lie at precision medicine and systems biology. His lab integrates engineering, computational and biological techniques to study cancer, stem cells, microbiota and the nervous system in the gut. This multidisciplinary work has been instrumental in initiating several translational clinical trials in precision therapy. He is the director of the Woo Center for Big Data and Precision Health (DAP) and a core member of the Center for Genomics and Computational Biology (GCB).
Positions:
Hawkins Family Associate Professor
Biomedical Engineering
Pratt School of Engineering
Associate Professor in the Department of Biomedical Engineering
Biomedical Engineering
Pratt School of Engineering
Associate Professor in the Department of Electrical and Computer Engineering
Electrical and Computer Engineering
Pratt School of Engineering
Associate Professor in Molecular Genetics and Microbiology
Molecular Genetics and Microbiology
School of Medicine
Associate Professor in Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
School of Medicine
Member of the Duke Cancer Institute
Duke Cancer Institute
School of Medicine
Affiliate of the Regeneration Next Initiative
Regeneration Next Initiative
School of Medicine
Education:
B.Sc. 2001
Stanford University
M.Sc. 2001
Stanford University
Ph.D. 2008
Stanford University
Grants:
A comprehensive research resource to define mechanisms underlying microbial regulation of host metabolism in pediatric obesity and obesity-targeted therapeutics
Administered By
Molecular Genetics and Microbiology
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
Administered By
Biomedical Engineering
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
An organotypic model recapitulating colon cancer microenvironment and metastasis
Administered By
Biomedical Engineering
Role
Principal Investigator
Start Date
End Date
T32-Diversity: NRSA Diversity Supplement Award
Administered By
Medicine, Gastroenterology
Awarded By
National Institutes of Health
Role
Co-Mentor
Start Date
End Date
Robust Control of the Stem Cell Niche
Administered By
Biomedical Engineering
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
Publications:
Mucosal Associated Invariant T (MAIT) Cell Responses Differ by Sex in COVID-19.
Sexual dimorphisms in immune responses contribute to coronavirus disease 2019 (COVID-19) outcomes, yet the mechanisms governing this disparity remain incompletely understood. We carried out sex-balanced sampling of peripheral blood mononuclear cells from confirmed COVID-19 inpatients and outpatients, uninfected close contacts, and healthy controls for 36-color flow cytometry and single cell RNA-sequencing. Our results revealed a pronounced reduction of circulating mucosal associated invariant T (MAIT) cells in infected females. Integration of published COVID-19 airway tissue datasets implicate that this reduction represented a major wave of MAIT cell extravasation during early infection in females. Moreover, female MAIT cells possessed an immunologically active gene signature, whereas male counterparts were pro-apoptotic. Collectively, our findings uncover a female-specific protective MAIT profile, potentially shedding light on reduced COVID-19 susceptibility in females.
Authors
MLA Citation
Yu, Chen, et al. “Mucosal Associated Invariant T (MAIT) Cell Responses Differ by Sex in COVID-19.” Med (N Y), Apr. 2021. Pubmed, doi:10.1016/j.medj.2021.04.008.
URI
https://scholars.duke.edu/individual/pub1480358
PMID
33870241
Source
pubmed
Published In
Med (N Y)
Published Date
DOI
10.1016/j.medj.2021.04.008
Mapping the peripheral nervous system in the whole mouse via compressed sensing tractography.
Objective.The peripheral nervous system (PNS) connects the central nervous system with the rest of the body to regulate many physiological functions and is therapeutically targeted to treat diseases such as epilepsy, depression, intestinal dysmotility, chronic pain, and more. However, we still lack understanding of PNS innervation in most organs because the large span, diffuse nature, and small terminal nerve bundle fibers have precluded whole-organism, high resolution mapping of the PNS. We sought to produce a comprehensive peripheral nerve atlas for use in future interrogation of neural circuitry and selection of targets for neuromodulation.Approach.We used diffusion tensor magnetic resonance imaging (DT-MRI) with high-speed compressed sensing to generate a tractogram of the whole mouse PNS. The tractography generated from the DT-MRI data is validated using lightsheet microscopy on optically cleared, antibody stained tissue.Main results.Herein we demonstrate the first comprehensive PNS tractography in a whole mouse. Using this technique, we scanned the whole mouse in 28 h and mapped PNS innervation and fiber network in multiple organs including heart, lung, liver, kidneys, stomach, intestines, and bladder at 70µm resolution. This whole-body PNS tractography map has provided unparalleled information; for example, it delineates the innervation along the gastrointestinal tract by multiple sacral levels and by the vagal nerves. The map enabled a quantitative tractogram that revealed relative innervation of the major organs by each vertebral foramen as well as the vagus nerve.Significance.This novel high-resolution nerve atlas provides a potential roadmap for future neuromodulation therapies and other investigations into the neural circuits which drive homeostasis and disease throughout the body.
Authors
MLA Citation
Garrett, Aliesha, et al. “Mapping the peripheral nervous system in the whole mouse via compressed sensing tractography.” Journal of Neural Engineering, vol. 18, no. 4, June 2021. Epmc, doi:10.1088/1741-2552/ac0089.
URI
https://scholars.duke.edu/individual/pub1481735
PMID
33979784
Source
epmc
Published In
Journal of Neural Engineering
Volume
18
Published Date
DOI
10.1088/1741-2552/ac0089
The frontier of live tissue imaging across space and time.
What you see is what you get-imaging techniques have long been essential for visualization and understanding of tissue development, homeostasis, and regeneration, which are driven by stem cell self-renewal and differentiation. Advances in molecular and tissue modeling techniques in the last decade are providing new imaging modalities to explore tissue heterogeneity and plasticity. Here we describe current state-of-the-art imaging modalities for tissue research at multiple scales, with a focus on explaining key tradeoffs such as spatial resolution, penetration depth, capture time/frequency, and moieties. We explore emerging tissue modeling and molecular tools that improve resolution, specificity, and throughput.
Authors
Huang, Q; Garrett, A; Bose, S; Blocker, S; Rios, AC; Clevers, H; Shen, X
MLA Citation
Huang, Qiang, et al. “The frontier of live tissue imaging across space and time.” Cell Stem Cell, vol. 28, no. 4, Apr. 2021, pp. 603–22. Epmc, doi:10.1016/j.stem.2021.02.010.
URI
https://scholars.duke.edu/individual/pub1477860
PMID
33798422
Source
epmc
Published In
Cell Stem Cell
Volume
28
Published Date
Start Page
603
End Page
622
DOI
10.1016/j.stem.2021.02.010
Abstract 5479: Targeting fructose-induced metabolic reprogramming in liver metastasis
Authors
MLA Citation
Shen, Xiling. “Abstract 5479: Targeting fructose-induced metabolic reprogramming in liver metastasis.” Molecular and Cellular Biology / Genetics, American Association for Cancer Research, 2018. Crossref, doi:10.1158/1538-7445.am2018-5479.
URI
https://scholars.duke.edu/individual/pub1393483
Source
crossref
Published In
Molecular and Cellular Biology / Genetics
Published Date
DOI
10.1158/1538-7445.am2018-5479
Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
SARS-CoV-2 infection has been shown to trigger a wide spectrum of immune responses and clinical manifestations in human hosts. Here, we sought to elucidate novel aspects of the host response to SARS-CoV-2 infection through RNA sequencing of peripheral blood samples from 46 subjects with COVID-19 and directly comparing them to subjects with seasonal coronavirus, influenza, bacterial pneumonia, and healthy controls. Early SARS-CoV-2 infection triggers a powerful transcriptomic response in peripheral blood with conserved components that are heavily interferon-driven but also marked by indicators of early B-cell activation and antibody production. Interferon responses during SARS-CoV-2 infection demonstrate unique patterns of dysregulated expression compared to other infectious and healthy states. Heterogeneous activation of coagulation and fibrinolytic pathways are present in early COVID-19, as are IL1 and JAK/STAT signaling pathways, which persist into late disease. Classifiers based on differentially expressed genes accurately distinguished SARS-CoV-2 infection from other acute illnesses (auROC 0.95 [95% CI 0.92-0.98]). The transcriptome in peripheral blood reveals both diverse and conserved components of the immune response in COVID-19 and provides for potential biomarker-based approaches to diagnosis.
Authors
McClain, MT; Constantine, FJ; Henao, R; Liu, Y; Tsalik, EL; Burke, TW; Steinbrink, JM; Petzold, E; Nicholson, BP; Rolfe, R; Kraft, BD; Kelly, MS; Saban, DR; Yu, C; Shen, X; Ko, EM; Sempowski, GD; Denny, TN; Ginsburg, GS; Woods, CW
MLA Citation
McClain, Micah T., et al. “Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.” Nat Commun, vol. 12, no. 1, Feb. 2021, p. 1079. Pubmed, doi:10.1038/s41467-021-21289-y.
URI
https://scholars.duke.edu/individual/pub1474600
PMID
33597532
Source
pubmed
Published In
Nature Communications
Volume
12
Published Date
Start Page
1079
DOI
10.1038/s41467-021-21289-y

Hawkins Family Associate Professor
Contact:
2167 Ciemas, 101 Science Dr, Box 3382, Durham, NC 27708
2167 Ciemas, 101 Science Drive, Box 3382, Durham, NC 27708